|
|
| | UR-144 N-(4-hydroxypentyl) metabolite-d5 Basic information |
| | UR-144 N-(4-hydroxypentyl) metabolite-d5 Chemical Properties |
| solubility | DMF: 30 mg/ml
DMSO: 30 mg/ml
Ethanol: 30 mg/ml |
| | UR-144 N-(4-hydroxypentyl) metabolite-d5 Usage And Synthesis |
| Description | UR-144 N-(4-hydroxypentyl) metabolite-d5 (Item No. 14374) is intended for use as an internal standard for the quantification of UR-144 N-(4-hydroxypentyl) metabolite by GC- or LC-mass spectrometry (MS). UR-144 (Item No. 11502) is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).1 UR-144 N-(4-hydroxypentyl) metabolite is an expected phase I metabolite of UR-144, based on the metabolism of similar cannabimimetics.2,3 It is possible that this metabolite may be detectable in either serum or urine.2,3 The physiological and toxicological properties of this compound have not been tested. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | | References | [1] JENNIFER M. FROST*. Indol-3-ylcycloalkyl Ketones: Effects of N1 Substituted Indole Side Chain Variations on CB2 Cannabinoid Receptor Activity[J]. Journal of Medicinal Chemistry, 2009, 53 1: 295-315. DOI: 10.1021/jm901214q
[2] ANNETTE WINTERMEYER. In vitro phase I metabolism of the synthetic cannabimimetic JWH-018[J]. Analytical and Bioanalytical Chemistry, 2010, 398 5: 2141-2153. DOI: 10.1007/s00216-010-4171-0
[3] KRISHNA C. CHIMALAKONDA. Solid-Phase Extraction and Quantitative Measurement of Omega and Omega-1 Metabolites of JWH-018 and JWH-073 in Human Urine[J]. Analytical Chemistry, 2011, 83 16: 6381-6388. DOI: 10.1021/ac201377m |
| | UR-144 N-(4-hydroxypentyl) metabolite-d5 Preparation Products And Raw materials |
|